Zhuotao R. Yang

Hangzhou, 310014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Poria cocos-derived exosome-like nanoparticles ameliorate lymphedema by reprogramming fibroblast metabolism via enhanced TCA cycle flux.

Poria cocos-derived exosome-like nanoparticles ameliorate lymphedema by reprogramming fibroblast metabolism via enhanced TCA cycle flux.

Journal: Journal of nanobiotechnology

Published: December 24, 2025

Cation homeostasis-related prognostic genes uncovered by transcriptomic analysis in breast cancer.

Cation homeostasis-related prognostic genes uncovered by transcriptomic analysis in breast cancer.

Journal: Translational cancer research

Published: December 17, 2025

Z-Guggulsterone Inhibits Triple-Negative Breast Cancer Progression by Blocking Autophagosome-Lysosome Fusion via OGT-Mediated SNAP29 O-GlcNAcylation.

Z-Guggulsterone Inhibits Triple-Negative Breast Cancer Progression by Blocking Autophagosome-Lysosome Fusion via OGT-Mediated SNAP29 O-GlcNAcylation.

Journal: Phytotherapy research : PTR

Published: November 26, 2025

UBE2K promotes breast cancer growth by ubiquitinating and degrading STUB1 to regulate the PKA/CREB1 signaling pathway, forming a feedback loop.

UBE2K promotes breast cancer growth by ubiquitinating and degrading STUB1 to regulate the PKA/CREB1 signaling pathway, forming a feedback loop.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 03, 2025

Development of glucagon-like Peptide-1 lysosomal targeting chimeras for degradation of extracellular and membrane proteins.

Development of glucagon-like Peptide-1 lysosomal targeting chimeras for degradation of extracellular and membrane proteins.

Journal: European journal of medicinal chemistry

Published: October 26, 2025

Identification of Potential Therapeutic Targets for Xihuang Pill in Breast Cancer: A Mendelian Randomization and Experimental Study.

Identification of Potential Therapeutic Targets for Xihuang Pill in Breast Cancer: A Mendelian Randomization and Experimental Study.

Journal: Breast cancer (Dove Medical Press)

Published: October 09, 2025

Mechanistic evaluation of pachymic acid in breast cancer via network pharmacology and in vitro validation.

Mechanistic evaluation of pachymic acid in breast cancer via network pharmacology and in vitro validation.

Journal: BMC complementary medicine and therapies

Published: August 18, 2025

Corrigendum to "Engineered macrophages in breast cancer: bridging targeted therapy and advanced drug delivery" [Int. Immunopharmacol. 163 (2025) 115237].

Corrigendum to "Engineered macrophages in breast cancer: bridging targeted therapy and advanced drug delivery" [Int. Immunopharmacol. 163 (2025) 115237].

Journal: International immunopharmacology

Published: July 26, 2025

Engineered macrophages in breast Cancer: bridging targeted therapy and advanced drug delivery.

Engineered macrophages in breast Cancer: bridging targeted therapy and advanced drug delivery.

Journal: International immunopharmacology

Published: May 24, 2025

Tumor-colonizing Pseudoalteromonas elyakovii metabolically reprograms the tumor microenvironment and promotes breast ductal carcinoma.

Tumor-colonizing Pseudoalteromonas elyakovii metabolically reprograms the tumor microenvironment and promotes breast ductal carcinoma.

Journal: mBio

Published: April 07, 2025

Clinicopathological features of composite pheochromocytoma

Clinicopathological features of composite pheochromocytoma

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: February 20, 2020

Low grade fibromyxiod sarcoma in children: a clinicopathological analysis

Low grade fibromyxiod sarcoma in children: a clinicopathological analysis

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: January 10, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026